Viridian Therapeutics, Inc.\DE ($VRDN)
Filing Information
| Accession Number | 0001193125-26-359636 |
|---|---|
| Form Type | 4 |
| Filing Date | Aug 21, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
34,212
Total Value
$492,294.00
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Legal Officer | Common Stock | โ | Aug 19, 2026 | Sale | 4,212 | $24.50 | $103,194.00 | 0 | Direct | โ | View Details | |
Chief Legal Officer | Common Stock | โ | Aug 19, 2026 | Exercise/Conversion | 10,000 | $14.41 | $144,100.00 | 10,000 | Direct | โ | View Details | |
Chief Legal Officer | Common Stock | โ | Aug 19, 2026 | Sale | 10,000 | $24.50 | $245,000.00 | 0 | Direct | โ | View Details | |
Chief Legal Officer | Stock Option (Right to Buy) | Derivative | Aug 19, 2026 | Exercise/Conversion | 10,000 | $0.00 | $0.00 | 114,072 | Direct | โ | View Details |